Mixed Results for Adjuvant Pembro in Endometrial Cancer ...Middle East

Medscape - News
Adding adjuvant pembrolizumab to chemotherapy only led to a benefit in patients with mismatch repair-deficient high-risk endometrial cancers, a phase 3 trial found. Medscape Medical News

Hence then, the article about mixed results for adjuvant pembro in endometrial cancer was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Mixed Results for Adjuvant Pembro in Endometrial Cancer )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News